**Author details**

Jorge Silva Enciso\* and Kimberly N. Hong Cardiovascular Medicine Institute, University of California San Diego, San Diego, CA, US

\*Address all correspondence to: jsilvaenciso@ucsd.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**163**

*ECMO Weaning Strategies to Optimize Outcomes DOI: http://dx.doi.org/10.5772/intechopen.85614*

> et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: A meta-analysis of 1,866 adult patients. The Annals of Thoracic Surgery.

> [7] Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. The Journal of Thoracic and Cardiovascular

Surgery. 2010;**139**(2):302-311

[8] Carroll BJ, Shah RV, Murthy V, McCullough SA, Reza N, Thomas SS, et al. Clinical features and outcomes in adults with cardiogenic shock

[9] Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, et al. Early

extracorporeal membrane oxygenatorassisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction

complicated with profound cardiogenic

shock. Critical Care Medicine.

[10] Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: A weighted meta-analysis of 170 patients. Journal of Cardiac Failure.

[11] Bermudez CA, Rocha RV, Toyoda Y, Zaldonis D, Sappington PL, Mulukutla S, et al. Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy. The Annals of Thoracic

Surgery. 2011;**92**(6):2125-2131

2010;**38**(9):1810-1817

2014;**20**(6):400-406

supported by extracorporeal membrane oxygenation. The American Journal of Cardiology. 2015;**116**(10):1624-1630

2014;**97**(2):610-616

[1] Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. The New England Journal of Medicine.

[2] Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: Incidence, outcomes and cost analysis. Journal of the American College of Cardiology.

[3] Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. SCAI/ ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: Endorsed by the American Heart Assocation, the cardiological society of India, and

sociedad latino Americana de Cardiologia Intervencion; Affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. Journal of the American College of Cardiology. 2015,

[4] Xie A, Phan K, Tsai YC, Yan TD, Forrest P. Venoarterial extracorporeal

[5] Affronti A, di Bella I, Carino D, Ragni T. Levosimendan may improve weaning outcomes in venoarterial ECMO patients. ASAIO Journal.

[6] Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J,

membrane oxygenation for cardiogenic shock and cardiac arrest: A meta-analysis. Journal of Cardiothoracic and Vascular Anesthesia.

**References**

1999;**341**(9):625-634

2014;**64**(14):1407-1415

2015;**65**(19):e7-e26

2015;**29**(3):637-645

2013;**59**(6):554-557

*ECMO Weaning Strategies to Optimize Outcomes DOI: http://dx.doi.org/10.5772/intechopen.85614*
